Yoshiaki Fukuda

1.6k total citations
62 papers, 1.2k citations indexed

About

Yoshiaki Fukuda is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Yoshiaki Fukuda has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 21 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in Yoshiaki Fukuda's work include Mast cells and histamine (19 papers), Asthma and respiratory diseases (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Yoshiaki Fukuda is often cited by papers focused on Mast cells and histamine (19 papers), Asthma and respiratory diseases (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Yoshiaki Fukuda collaborates with scholars based in Japan, United States and Australia. Yoshiaki Fukuda's co-authors include Yoshiaki Tomimori, Yoshitaka Tanaka, Masao Murakawa, Megumi Goto, Kazuhiro Nagahira, Toshihiro Nakanishi, Kayo Saito, Tsuyoshi Muto, Takashi Nakatsuka and Hiroshi Nakazato and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of the Acoustical Society of America and Physical Chemistry Chemical Physics.

In The Last Decade

Yoshiaki Fukuda

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Fukuda Japan 20 454 420 197 190 156 62 1.2k
Henry L. Meier United States 17 152 0.3× 301 0.7× 217 1.1× 144 0.8× 221 1.4× 44 1.1k
Susumu Muto Japan 25 297 0.7× 886 2.1× 50 0.3× 68 0.4× 136 0.9× 55 1.9k
Michael K. Bach United States 22 395 0.9× 642 1.5× 267 1.4× 69 0.4× 573 3.7× 70 1.9k
J. David Kieffer United States 26 670 1.5× 853 2.0× 300 1.5× 213 1.1× 291 1.9× 44 2.7k
Satoru Yamasaki Japan 19 741 1.6× 789 1.9× 200 1.0× 41 0.2× 184 1.2× 37 2.5k
Leonard C. Harber United States 32 306 0.7× 1.3k 3.2× 145 0.7× 1.1k 5.6× 140 0.9× 87 3.0k
Lijing Xu Canada 22 391 0.9× 287 0.7× 172 0.9× 39 0.2× 485 3.1× 43 1.3k
F.V. Vega Spain 13 433 1.0× 332 0.8× 101 0.5× 41 0.2× 248 1.6× 26 1.1k
Thomas M. Mariano United States 22 844 1.9× 667 1.6× 30 0.2× 155 0.8× 75 0.5× 37 2.0k
Tim H. Holmström Finland 18 294 0.6× 1.2k 2.9× 57 0.3× 29 0.2× 62 0.4× 22 1.7k

Countries citing papers authored by Yoshiaki Fukuda

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Fukuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Fukuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Fukuda more than expected).

Fields of papers citing papers by Yoshiaki Fukuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Fukuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Fukuda. The network helps show where Yoshiaki Fukuda may publish in the future.

Co-authorship network of co-authors of Yoshiaki Fukuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Fukuda. A scholar is included among the top collaborators of Yoshiaki Fukuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Fukuda. Yoshiaki Fukuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukai, T., et al.. (2025). Broadband Characteristics of Target Strength of Pacific Chub Mackerel. Fishes. 10(2). 51–51.
2.
Mukai, T., et al.. (2023). Broadband target strength of arabesque greenling, Pacific sand lance, and pointhead flounder. ICES Journal of Marine Science. 81(1). 195–203. 5 indexed citations
3.
Fukuda, Yoshiaki, T. Mukai, Kouichi Sawada, & Kohji Iida. (2013). Measurement of Target Strength of <i>Euphausia pacifica</i> Using a High-Frequency Broadband Signal. 40(3). 138–148. 1 indexed citations
4.
Fukuda, Yoshiaki, et al.. (2012). Lateral target strength of Euphausia pacifica measured by a tethered method. NIPPON SUISAN GAKKAISHI. 78(3). 388–398. 3 indexed citations
5.
Terakawa, Maki, Tsuyoshi Muto, Hiroshi Maruoka, et al.. (2011). Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients. International Immunopharmacology. 11(10). 1628–1632. 7 indexed citations
6.
Goto, Megumi, Masao Murakawa, Yoshitaka Tanaka, et al.. (2010). Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo. European Journal of Pharmacology. 633(1-3). 93–97. 18 indexed citations
7.
Goto, Megumi, Masao Murakawa, Yoshitaka Tanaka, et al.. (2009). ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-α level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice. European Journal of Pharmacology. 613(1-3). 163–166. 17 indexed citations
8.
Terakawa, Maki, Yoshiaki Tomimori, Tsuyoshi Muto, et al.. (2008). Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis. European Journal of Pharmacology. 601(1-3). 186–191. 25 indexed citations
9.
Murakawa, Masao, Megumi Goto, Yoshitaka Tanaka, et al.. (2008). Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte. International Immunopharmacology. 9(1). 97–102. 23 indexed citations
10.
Fukuda, Yoshiaki, et al.. (2005). Next Generation Building Material MOISS. Journal of the Clay Science Society of Japan. 44(3). 118–123. 1 indexed citations
11.
Tomimori, Yoshiaki, Yoshitaka Tanaka, Megumi Goto, & Yoshiaki Fukuda. (2005). Repeated Topical Challenge with Chemical Antigen Elicits Sustained Dermatitis in NC/Nga Mice in Specific-Pathogen-Free Condition. Journal of Investigative Dermatology. 124(1). 119–124. 63 indexed citations
12.
Terakawa, Maki, Yoshiaki Tomimori, Megumi Goto, et al.. (2005). Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathway. Biochemical and Biophysical Research Communications. 332(4). 969–975. 17 indexed citations
13.
Fukuda, Yoshiaki, Hiroshi Kawashima, Kayo Saito, et al.. (2000). Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models. European Journal of Pharmacology. 390(1-2). 203–207. 34 indexed citations
14.
Nagahira, Kazuhiro, Yoshiaki Fukuda, Hiroshi Kawashima, et al.. (1998). Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-α. Immunology Letters. 64(2-3). 139–144. 4 indexed citations
15.
Fukuda, Yoshiaki, et al.. (1997). Fucoidin, a potent inhibitor of l-selectin function, reduces contact hypersensitivity reaction in mice. Immunology Letters. 59(1). 47–51. 17 indexed citations
16.
Nagahira, Kazuhiro, et al.. (1995). Epitope mapping of monoclonal antibodies to tumor necrosis factor-α by synthetic peptide approach. Immunology Letters. 46(1-2). 135–141. 11 indexed citations
17.
Fukuda, Yoshiaki, et al.. (1994). Suppression of cytochrome P450IA1 by interleukin-6 in human HepG2 hepatoma cells. Biochemical Pharmacology. 47(7). 1187–1195. 57 indexed citations
18.
Fukuda, Yoshiaki, Hiroyoshi Fujita, Shigeru Taketani, & Shigeru Sassa. (1993). Haem is necessary for a continued increase in ferrochelatase mRNA in murine erythroleukaemia cells during erythroid differentiation. British Journal of Haematology. 85(4). 670–675. 13 indexed citations
19.
Fukuda, Yoshiaki, et al.. (1992). Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells. Biochemical and Biophysical Research Communications. 184(2). 960–965. 86 indexed citations
20.
Nagasawa, Masao, Hironobu Koga, Yoshiaki Fukuda, et al.. (1984). A Case of Legionnaires' Disease and Branhamella catarrhalis Pneumonia Complicated with Malignant Lymphoma. Kansenshogaku zasshi. 58(9). 936–942. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry L. Meier Breakdown of academic impact, for papers by Susumu Muto Breakdown of academic impact, for papers by Michael K. Bach Breakdown of academic impact, for papers by J. David Kieffer Breakdown of academic impact, for papers by Satoru Yamasaki Breakdown of academic impact, for papers by Leonard C. Harber Breakdown of academic impact, for papers by Lijing Xu Breakdown of academic impact, for papers by F.V. Vega Breakdown of academic impact, for papers by Thomas M. Mariano Breakdown of academic impact, for papers by Tim H. Holmström
Rankless by CCL
2026